Bdo Wealth Advisors, LLC Sage Therapeutics, Inc. Transaction History

Bdo Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$40.26 - $57.37 $7,246 - $10,326	-180 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $7,885 - $12,023	135 Added 300.0%	180 $16,000
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $1,176 - $3,475	45 New	45 $1,000
Q3 2018 Nov 07, 2018	SELL	$138.11 - $169.04 $8,977 - $10,987	-65 Closed	0 $0
Q2 2018 Aug 27, 2018	BUY	$140.36 - $175.76 $9,123 - $11,424	65 New	65 $10,000

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $631M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.